|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 22, No 5 (March 1), 2004: pp. 953-954 © 2004 American Society of Clinical Oncology. DOI: 10.1200/JCO.2004.03.198
Difficult Diagnostic and Therapeutic CasesCASE 1. True Thymic Hyperplasia in a Patient Treated for T-Cell LymphomaUnit of Hematopathology, Institute of Hematology and Clinical Oncology L. & A. Seràgnoli, Bologna University, St Orsola Hospital, Bologna; Institute of Hematology, Perugia University, Perugia, Italy; and Institute of Pathology, Basel University, Basel, Switzerland A 24-year-old woman presented with rapidly enlarging supraclavicular lymphadenopathy. Biopsy showed complete effacement of the lymph node by a neoplastic population morphologically consistent with lymphoma/leukemia of precursor T-lymphocytes (so-called T-cell lymphoblastic lymphoma/leukemia). The phenotypic profile was as follows: CD34+, TdT+, CD3+, CD1a-, CD4-, CD8-, and Ki-67/MIB-1 95%. No involvement of the bone marrow and peripheral blood was found. She underwent chemotherapy according to the L2 protocol, followed by autologous bone marrow transplantation, which produced complete remission. Six months later, a follow-up computed tomography scan displayed a newly developed mass in the anterior-superior mediastinum that was regarded as suspicious for disease relapse (Fig 1). Given that no other signs and symptoms of malignant lymphoma were present, the mediastinal tumor was surgically removed. On gross examination, it was an encapsulated bilobate mass that measured 11 x 8 x 3.5 cm and weighed 180 g. At light microscopy, the mass consisted of normal thymic tissue with typical lobular architecture, Hassall's corpuscles, and well-defined cortical and medullary compartments (Fig 2, low power with cortex on left and medulla with Hassall's corpuscles on right; Fig 3, high power, with cortical thymocytes and admixed macrophages and epithelial cells). Immunohistochemistry on paraffin sections were carried out by the alkaline phosphatase-antialkaline phosphatase complexes technique [1] with application of specific antibodies against cytokeratins, CD1a, CD2, CD3, CD4, CD8, CD20, CD30, Bcl-2 oncogene product, Bcl-6 protein, TdT, Oct-1, Oct-2, BOB.1, and Ki-67, which showed the expected positivities both in the cortex and medulla [2,3] for true thymic hyperplasia (TTH). Most, if not all, cortical thymocytes did express the proliferation-associated nuclear antigen Ki-67. Interestingly, no lymphoid follicles were observed, in contrast to the thymic lymphoid hyperplasia occurring in patients with myasthenia gravis and other autoimmune disorders [4]. Twenty-eight months after the onset of disease, the patient died of acute respiratory failure as a result of Cytomegalovirus pneumonitis. Unfortunately, the permission for autopsy was denied.
TTH is a rare condition, consisting of enlargement of the thymus gland beyond the upper limits for the corresponding age. It can be related to "stressing" events, such as surgery [5], thermal burns [6], chemotherapy [7], and hyperthyroidism [8,9], or can represent an idiopathic condition [10]. In particular, it has been regarded as a rebound immunologic phenomenon [11], usually regressing in a few months either spontaneously or after steroid therapy. Based on the present case, one should be aware that in patients with a previous history of T-cell lymphoblastic lymphoma/leukemia or other malignancy, a newly developing mediastinal mass does not always herald a disease relapse with TTH belonging to the spectrum of possible underlying conditions. Notably, under these circumstances, the positron emission tomography scan is of no diagnostic value, since both TTH and T-cell lymphoblastic lymphoma/leukemia consist of highly proliferating cells that avidly uptake 2-deoxy-2 fluoro-D-glucose. In order to achieve the correct diagnosis and to avoid the risk of inappropriate therapeutic decisions (including chemotherapy and total thymectomy), a biopsy is warranted, which should be as large as to allow the identification of the normal thymic structure in case of TTH versus organ infiltration with destruction of the epithelial network in T-cell lymphoblastic lymphoma/leukemia. Authors' Disclosures of Potential Conflicts of Interest The authors indicated no potential conflicts of interest.
REFERENCES 1. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219229, 1984[Abstract]
2. Hyjek E, Chadburn A, Liu YF, et al: BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood 97:270276, 2001
3. Marafioti T, Ascani S, Pulford K, et al: Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol 162:861871, 2003 4. Pirronti T, Rinaldi P, Batocchi AP, et al: Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings. Acta Radiol 43:380384, 2002[CrossRef][Medline] 5. Rizk G, Cueto L, Amplatz K: Rebound enlargement of the thymus after successful corrective surgery for transposition of the great vessels. Am J Roentgenol Radium Ther Nucl Med 116:528530, 1972[Medline] 6. Lee Y, Moallem S, Clauss RH: Massive hyperplastic thymus in a 22 month old infant. Ann Thorac Surg 27:356358, 1979[Abstract] 7. Mishra SK, Melinkeri SR, Dabadghoo S: Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia. Eur J Haematol 67:252254, 2001[CrossRef][Medline]
8. Budavari AI, Whitaker MD, Helmers RA: Thymic hyperplasia presenting as anterior mass in 2 patients with Graves disease. Mayo Clin Proc 77:495499, 2002 9. Inoue K, Sugio K, Inoue T, et al: Hyperplasia of the thymic gland in a patient with Graves' disease. Ann Thorac Cardiovasc Surg 6:397400, 2000[Medline] 10. Woywodt A, Verhaart S, Kiss A: Massive true thymic hyperplasia. Eur J Pediatr Surg 9:331333, 1999[Medline] 11. Suster S, Rosai J: Thymus, in Sternberg SS (ed): Histology for pathologists. New York, Raven Press, 1992, pp 261277
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|